Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoujun Zhao

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.
The Journal of Urology|June 11, 2020
Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate CancerPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2008
Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapyTim Joseph, David A McKenna, Antonio C Westphalen, et al.
Radiology|February 9, 2008
Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experienceDavid A McKenna, Fergus V Coakley, Antonio C Westphalen, et al.
The Journal of Urology|September 24, 2020
Reply by AuthorsPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
Cancer Medicine|September 19, 2023
Ten-year work burden after prostate cancer treatmentSamuel L Washington, Peter E Lonergan, Janet E Cowan, et al.
Molecular Imaging|September 28, 2010
In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional labelElizabeth Jane Sutton, Tobias D Henning, Sophie Boddington, et al.
Radiology|November 21, 2007
Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imagingAntonio C Westphalen, Fergus V Coakley, Aliya Qayyum, et al.
European Journal of Epidemiology|October 26, 2022
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formulaLouisa H Smith, Xabier García-Albéniz, June M Chan, et al.
The Journal of Urology|May 16, 2019
Trends in Complementary and Alternative Medicine Use among Patients with Prostate CancerKyle B Zuniga, Shoujun Zhao, Stacey A Kenfield, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.
The Journal of Urology|June 11, 2020
Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate CancerPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2008
Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapyTim Joseph, David A McKenna, Antonio C Westphalen, et al.
Radiology|February 9, 2008
Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experienceDavid A McKenna, Fergus V Coakley, Antonio C Westphalen, et al.
The Journal of Urology|September 24, 2020
Reply by AuthorsPeter E Lonergan, Samuel L Washington, Janet E Cowan, et al.
Cancer Medicine|September 19, 2023
Ten-year work burden after prostate cancer treatmentSamuel L Washington, Peter E Lonergan, Janet E Cowan, et al.
Molecular Imaging|September 28, 2010
In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional labelElizabeth Jane Sutton, Tobias D Henning, Sophie Boddington, et al.
Radiology|November 21, 2007
Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imagingAntonio C Westphalen, Fergus V Coakley, Aliya Qayyum, et al.
European Journal of Epidemiology|October 26, 2022
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formulaLouisa H Smith, Xabier García-Albéniz, June M Chan, et al.
The Journal of Urology|May 16, 2019
Trends in Complementary and Alternative Medicine Use among Patients with Prostate CancerKyle B Zuniga, Shoujun Zhao, Stacey A Kenfield, et al.
Pageof 7